BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
Medtronic
Farmers Insurance
Merck
Baxter
Julphar
Chinese Patent Office
Covington
Boehringer Ingelheim

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019787

« Back to Dashboard

NDA 019787 describes NORVASC, which is a drug marketed by Pfizer and is included in one NDA. It is available from nine suppliers. Additional details are available on the NORVASC profile page.

The generic ingredient in NORVASC is amlodipine besylate. There are fifty drug master file entries for this compound. Seventy-nine suppliers are listed for this compound. Additional details are available on the amlodipine besylate profile page.
Summary for 019787
Tradename:NORVASC
Applicant:Pfizer
Ingredient:amlodipine besylate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019787
Ingredient-typeDihydropyridines
Mechanism of ActionCalcium Channel Antagonists
Suppliers and Packaging for NDA: 019787
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORVASC amlodipine besylate TABLET;ORAL 019787 NDA Pfizer Laboratories Div Pfizer Inc 0069-1520 0069-1520-68 90 TABLET in 1 BOTTLE (0069-1520-68)
NORVASC amlodipine besylate TABLET;ORAL 019787 NDA Pfizer Laboratories Div Pfizer Inc 0069-1530 0069-1530-72 300 TABLET in 1 BOTTLE (0069-1530-72)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 2.5MG BASE
Approval Date:Jul 31, 1992TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:Jul 31, 1992TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Jul 31, 1992TE:ABRLD:Yes

Expired US Patents for NDA 019787

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-003 Jul 31, 1992 ➤ Subscribe ➤ Subscribe
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-001 Jul 31, 1992 ➤ Subscribe ➤ Subscribe
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-001 Jul 31, 1992 ➤ Subscribe ➤ Subscribe
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-003 Jul 31, 1992 ➤ Subscribe ➤ Subscribe
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-002 Jul 31, 1992 ➤ Subscribe ➤ Subscribe
Pfizer NORVASC amlodipine besylate TABLET;ORAL 019787-002 Jul 31, 1992 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
AstraZeneca
Chinese Patent Office
Julphar
Cantor Fitzgerald
Deloitte
Baxter
Teva
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot